Skip to Main Content

Paper Details

Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan.
Bone Marrow Transplant
1
2022
Author NameAffiliation
Francesc X Avil??sHospital Clinic de Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)
Francesc X Avil??sJosep Carreras Leukemia Research Institute
  • 1 - 2

Datasets

Release 1.2